Clinical Research Directory

Inclusion criteria : 24 patients divided in : * 6 patients with low risk prostate cancer (Gleason score ≤ 6 and cT1-T2a and Prostate Specific Antigen (PSA) value \< 10 ng/mL) * 12 patients with intermediate risk prostate cancer (Gleason score 7 or cT2b or PSA value 10-20 ng/mL) divided in : 6 patients who are Gleason score 7(3+4) (favourable intermediate risk) 6 patients who are Gleason score 7(4+3) (unfavourable intermediate risk) * 6 patients with high risk prostate cancer (Gleason \> 7 or cT2c or PSA value \> 20 ng/mL) * Candidate for radical prostatectomy after discussion in multidisciplinary committee * Covered by the national health insurance system * Written informed consent willingly obtained Exclusion criteria : * any kind of previous treatment for prostate cancer (hormonal treatment, EBRT, brachytherapy, cryotherapy, etc…); * patient not candidate for radical prostatectomy and/or unable to benefit from surgery * freedom deprivated patient by judiciary or administrative decision * patient under legal protection or unable to express its own consent * patient within exclusion period from another clinical trial * known contraindication to radiopharmaceuticals and / or excipients